Reine Allan, CEO of Prime Medicine, Inc. ($PRME), made one open market purchase of company shares in the last year, totaling $147 thousand, with the most recent on May 21, 2025. This ranks her 1,846th among nearly 5,000 insiders by purchase amount, below the average of $1.5 million across 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Executive Officer | A | Stock Option (right to buy) | 1300000 | $0.00 | 1,300,000.0000 | 180,510,658 | 9999.99% | 0.72% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Executive Officer | A | Stock Option (right to buy) | 850000 | $0.00 | 850,000.0000 | 131,160,842 | 9999.99% | 0.65% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Executive Officer | D | Stock Option (right to buy) | 850000 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.65% |
| May 21, 2025 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Executive Officer | P | Common Stock | 125000 | $1.18 | 125,000.0000 | 131,160,842 | 9999.99% | 0.10% |
| May 19, 2025 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Executive Officer | A | Stock Option (right to buy) | 2000000 | $0.00 | 2,000,000.0000 | 131,160,842 | 9999.99% | 1.52% |
| May 8, 2025 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Financial Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 850,000.0000 | 131,160,842 | 9.68% | 0.06% |
| Feb. 27, 2025 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Financial Officer | A | Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 131,160,842 | 9999.99% | 0.21% |
| Dec. 5, 2024 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Financial Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 775,000.0000 | 0 | 10.71% | 0.00% |
| May 17, 2024 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Financial Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2024 | Prime Medicine, Inc. | $PRME | Reine Allan | Chief Financial Officer | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |